SPIMACO establishes Dammam Pharma Company for SAR 120m:

11/09/2012 Argaam

SPEMACO Pharmaceutical plant announced today on tadawul establishing Dammam Pharmaceutical Company to construct a pharmaceutical products’ factory.

SPIMACO will have 80% interest in the new company, the rest to be owned by ARAC (SPIMACO affiliated co.).

The SAR 120m project is to be financed by the company’s internal resources as well as local banks and SIDF; Construction work is scheduled to be finished by the end of 2014.

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.